
The cold chain is an integral part of the pharmaceutical supply chain, ensuring that the temperature -sensitive products, such as biology, vaccines and personal medicines, reach patients safely and efficiently.
“Logipharma has always been about the unification of the pharmaceutical supply chain and the entire life sciences in one place. The importance of this event lies in its ability to destroy silos – the assembly of logistics leaders, supply chain experts, organizational professionals and technological innovators,” Will Robinson, director of Logipharma.
“By gathering all the main stakeholders under one roof, Logipharma enhances cooperation across the cross -sector, innovation, and the participation of best practices, making it the most important event for the professional pharmaceutical supply chain worldwide.” The attendees and Focus Logipharma expect approximately 2,500 senior attendees from all over the pharmaceutical industries and global biotechnology.
The delegate will represent a varied mix of companies, from major drug giants such as Pfizer, Novartis and GSK, to fast biotechnology companies and logistics service providers such as DHL, UPS and Kuehne+Nagel. Besides this, the organizers again enjoy the appointment of Logimed in this event, combining each knot at the end of the medical devices industry.
“Geographically, we expect strong participation from all over Europe, North America and APAC, with an increasing interest in emerging markets,” Robinson said. “The attendees will include the executives of the supply chain, logistical service managers, quality and compliance professionals, purchasing specialists and technology providers. The expansion of participation emphasizes the role of Logipharma as a major event for the leadership of innovation and cooperation in the industry.”
This year’s event will focus on many important topics that make up the industry today and in the future. Some major topics include:
• Digital transformation, data-based supply chains-how artificial intelligence, Blockchain, the Internet of Things revolution in the supply chain, predictive analyzes, and decision-making.
• Flexibility and Risk Management – Strategies to relieve disorders of geopolitical tensions, climate change, and raw materials.
• Sustainability and green logistics-pushing the industry towards the neutral supply chains of carbon, environmentally friendly packaging, and reducing emissions.
• Organizational compliance and global commercial challenges-adaptation to developing global regulations and ensuring final compliance in the face of new policies.
• Personal medicine and innovations of the cold chain-Logistics Services Management for Small Treatments, and ensuring integrity via complex distribution networks.
• Cooperation and partnership for success – how pharmaceutical companies, logistics service providers and technology companies can work more effectively.
The agenda is carefully designed to address the most urgent challenges and emerging trends in this industry. Some major sessions include:
• Executive keys and industry paintings – visions of senior executives in the supply chain in the future of logistics services.
• Paths and workshops-cover specific topics such as logistical services driven by artificial intelligence, temperature-dominated shipping, and organizational compliance.
• Innovation displays the latest supply chain technologies, automated operating tools, and actual time monitoring solutions.
• Round table networks and meetings 1: 1 – Providing opportunities for industrial leaders to communicate, exchange best practices and explore potential partnerships.
• Talk Talk – an opportunity to close the door under Chatham House and “lack of discussions” on the main pain points in the industry.
The twenty -fifth anniversary of the past 25 years, Logipharma has evolved and Marmaceutical Supply Bandscape significantly. When the event began, the focus was largely on improving traditional logistical models, simplifying distribution networks, and improving efficiency. Soon forward, the sector sees a more complicated environment – determined by digitization, sustainability, flexibility and organizational scrutiny.
“In particular, the cold chain has undergone dramatic changes. The rise of biology, cellular treatments and genes, and the challenges of distributing the Covid-19 vaccine have pushed the cold chain logs to the lighting of the light,” expressed.
“Innovations have turned such a actual temperature monitoring, managing the risks driven by artificial intelligence, and advanced packaging solutions how pharmaceutical companies manage sensitive temperature shipments. Logipharma reflected these industry transformations, as they grow from a specialized conference to a global platform where the largest players in Pharma and Med Tech, and logistics meet together to face challenges That was achieved.
“This twenty -fifth anniversary event is not just a milestone – it is an opportunity to look forward and form the next chapter of pharmaceutical supply chains. We are happy to welcome the brightest minds of industry to Lyon in April and we look forward to three days of innovation, cooperation and progress.”